Abstract
Secondary hemophagocytic lymphohistiocytosis has been reported after infections in immunocompromised hosts or in association with several malignancies. We report a case of secondary hemophagocytic syndrome after chemotherapy for multiple myeloma, which responded dramatically to dexamethasone, etoposide, and cyclosporin A.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biopsy, Needle
-
Bone Marrow / pathology
-
Cyclosporine / administration & dosage
-
Dexamethasone / administration & dosage
-
Etoposide / administration & dosage
-
Histiocytosis, Non-Langerhans-Cell / chemically induced*
-
Histiocytosis, Non-Langerhans-Cell / drug therapy*
-
Humans
-
Male
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / pathology
-
Treatment Outcome
Substances
-
Etoposide
-
Dexamethasone
-
Cyclosporine